Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

Insights on type I IFN signaling and regulation : studies of disease-associated TYK2 variants and of the negative regulators USP18/ISG15

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency

Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

Negative Regulation of Type I IFN Signaling by Phosphorylation of STAT 2 on T387

In search of a function for human type III interferons: insights from inherited and acquired deficits

Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway

Type I Interferons and Il-12: Convergence and Cross Regulation among Mediators of Cellular Immunity.

Human life within a narrow range: The lethal ups and downs of type I interferons

Deacetylase Sirtuin 1 mitigates type I IFN- and type II IFN-induced signaling and antiviral immunity

Type I interferon/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner

Regulating IRFs in IFN Driven Disease

Longitudinal system-based analysis of transcriptional responses to type I interferons

IRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies

Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism

Interferon target-gene expression and epigenomic signatures in health and disease

ID2 inhibits innate antiviral immunity by blocking TBK1- and IKKε-induced activation of IRF3

Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways

Dysregulation of Type I Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?

Negative Regulation of Virus-triggered IFN-β Signaling Pathway by Alternative Splicing of TBK1